Serum Urotensin II Levels in Patients with Non-Dipper Hypertension

REFERENCES

• Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. J Am Med Assoc 1996; 275(20):1571–1576.
   PubMed Web of Science ®Google Scholar
• Keeling DM, Isenberg DA. Haematological manifestations of systemic lupus erythematosus. Blood Rev 1993; 7(4):199–207.
   PubMed Web of Science ®Google Scholar
• Hess EV, Mongey AB. Drug-related lupus. Bull Rheum Dis 1991; 40(4):1–8.
   PubMedGoogle Scholar
• Mongey AB, Donovan-Brand R, Thomas TJ, Adams LE, Hess EV. Serologic evaluation of patients receiving procainamide. Arthritis Rheum 1992; 35(2):219–223.
   PubMed Web of Science ®Google Scholar
• Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins lupus pregnancy center experience. Arthritis Rheum 1991; 34(12):1538–1545.
   PubMed Web of Science ®Google Scholar
• Lockshin MD. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989; 32(6):665–670.
   PubMed Web of Science ®Google Scholar
• Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum 1993; 36(10):1392–1397.
   PubMed Web of Science ®Google Scholar
• Cervera R, Khamashta MA, Font J, . Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European working party on systemic lupus erythematosus. Medicine (Baltimore) 1993; 72(2):113–124.
   PubMed Web of Science ®Google Scholar
• Lom-Orta H, Alarcon-Segovia D, Diaz-Jouanen E. Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis. J Rheumatol 1980; 7(6):831–837.
   PubMed Web of Science ®Google Scholar
• Kharbanda RK, Deanfield JE. Functions of the healthy endothelium. Coron Artery Dis 2001; 12(6):485–491.
   PubMed Web of Science ®Google Scholar
• Maguire JJ, Kuc RE, Davenport AP. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 2000; 131(3):441–446.
   PubMed Web of Science ®Google Scholar
• Ong KL, Lam KS, Cheung BM. Urotensin II: its function in health and its role in disease. Cardiovasc Drugs Ther 2005; 19(1):65–75.
   PubMed Web of Science ®Google Scholar
• Lim M, Honisett S, Sparkes CD, . Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure. Circulation 2004; 109(10):1212–1214.
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertension 2007; 25(6):1105–1187.
   Google Scholar
• Franklin SS, Wt G, Wong ND, . Hemodynamic patterns of age-related changes in blood pressure. The Framingham heart study. Circulation 1997; 96(1):308–315.
   PubMed Web of Science ®Google Scholar
• Perlman JA, Wolf PH, Ray R, Lieberknecht G. Cardiovascular risk factors, premature heart disease, and all-cause mortality in a cohort of northern California women. Am J Obstet Gynecol 1988; 158(6 Pt 2):1568–1574.
   PubMed Web of Science ®Google Scholar
• Bousette N, Patel L, Douglas SA, Ohlstein EH, Giaid A. Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. Atherosclerosis 2004; 176(1):117–123.
   PubMed Web of Science ®Google Scholar
• Tzanidis A, Hannan RD, Thomas WG, . Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circ Res 2003; 93(3):246–253.
   PubMed Web of Science ®Google Scholar
• Ashenagar MS, Tabuchi M, Kinoshita K, . Gene expression in the adrenal glands of three spontaneously hypertensive rat substrains. Mol Med Report 2010; 3(2):213–222.
   Web of Science ®Google Scholar
• Kuwajima I, Suzuki Y, Shimosawa T, . Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J 1992; 123(5):1307–1311.
   PubMed Web of Science ®Google Scholar
• Rizzoni D. Relationship between initial cardiovascular structural-changes and daytime and nighttime blood-pressure monitoring. Am J Hypertens 1992; 5(3):180–186.
   PubMed Web of Science ®Google Scholar
• Kuller LH, Shemanski L, Psaty BM, . Subclinical disease as an independent risk factor for cardiovascular-disease. Circulation 1995; 92(4):720–726.
   PubMed Web of Science ®Google Scholar
• Gimelli A, Schneider-Eicke J, Neglia D, . Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy. J Am Coll Cardiol 1998; 31(2):366–373.
   PubMed Web of Science ®Google Scholar
• Mandinov L, Eberli FR, Seiler C, Hess OM. Diastolic heart failure. Cardiovasc Res 2000; 45(4):813–825.
   PubMed Web of Science ®Google Scholar
• Vasan RS, Benjamin EJ, Prevalence LD. Clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26(7):1565–1574.
   PubMed Web of Science ®Google Scholar
• Vasan RS, Levy D. The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. Arch Intern Med 1996; 156(16):1789–1796.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Porcellati C. Dippers versus non-dippers. J Hypertens 1991; 9(Suppl. 8):S42–S44.
   Google Scholar
• Verdecchia P, Schillaci G, Guerrieri M, . Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81(2):528–536.
   PubMed Web of Science ®Google Scholar
• Rizzo V, Maio FD, Campbell SV, . Left ventricular function, cardiac dysrhythmias, atrial activation, and volumes in nondipper hypertensive individuals with left ventricular hypertrophy. Am Heart J 2000; 139(3):529–536.
   PubMed Web of Science ®Google Scholar
• Rhee MY, Na SH, Kim YK, Lee MM, Kim HY. Acute effects of cigarette smoking on arterial stiffness and blood pressure in male smokers with hypertension. Am J Hypertens 2007; 20(6):637–641.
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Antoniadis D, Stefanadis C, . Relationships between new risk factors and circadian blood pressure variation in untreated subjects with essential hypertension. Am J Hypertens 2002; 15(7 Pt 1):600–604.
   PubMed Web of Science ®Google Scholar
• Akdeniz BGS, Badak Ö, Aslan Ö, Tamcı B. Hipertansiyon ve sol ventrikül hipertrofisinde ventriküler aritmi riski ve noninvaziv aritmi göstergeleri ile ilişkisi. Anadolu Kardiyoloji Dergisi 2002; 2(2):121–129.
   PubMedGoogle Scholar
• Tsoukas P, Kane E, Potential clinical Giaid A. implications of the urotensin II receptor antagonists. Front Pharmacol 2011; 2:38.
   Google Scholar